(Total Views: 479)
Posted On: 03/24/2020 12:31:58 PM
Post# of 145890
![Avatar](https://investorshangout.com/images/ProfileImages/947101588_48586_morph.jpg)
Re: craigakess #22885
Yes, they would very likely, especially since there is ZERO drugs that are approved for monotheraphy in HIV and 350mg pro 140 was pulling in 25-30% in p2 trial. They guy that even made the drug didn't even want to approval combo. Why would anyone with experience consider mono HIV a possibility after all that? It would have been canned, almost certainly by anyone else. Sometimes the people with the most experience don't see what is right in front of them, otherwise we wouldn't have Microsoft or Google.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)